Today on Pharmaceutical Technology
-
Less is more: why rare disease funding is on the up
http://www.pharmaceutical-technology.com/uploads/newsarticle/676888/main.jpgDespite reductions in R&D spending, clinical trials for rare diseases are going full steam ahead. Elly Earls speaks to Alastair Kent of Genetic Alliance UK, Tim Cote of the National...
-
Ahead in the cloud – a new home for clinical trial data
http://www.pharmaceutical-technology.com/uploads/newsarticle/676068/main.jpgAs the volume and complexity of clinical trial data grows, scientists need new ways to filter information. Elly Earls speaks to SAFE Bio-Pharma's Mollie Shields-Uehling and IBM's Chris Hines...
-
2012 Olympics Anti-Doping Laboratory
http://www.pharmaceutical-technology.com/projects/6914/main.jpgThe 2012 London Olympics will be the first Olympic event to have an anti-doping laboratory sponsored by a pharmaceutical...
-
Gulf Pharmaceutical Industries (Julphar) Insulin Production Facility
http://www.pharmaceutical-technology.com/projects/6893/main.jpgGulf Pharmaceutical Industries, known popularly as Julphar, is set to inaugurate the first ever insulin production facility in the Middle...
Latest Suppliers
With its Pharma Polymers product line, Evonik is a major provider of functional pharmaceutical excipients and advanced formulation...
Latest White Papers
With the tightening of R&D budgets and increased pressure from financial stakeholders, the pharmaceutical industry faces a great challenge in bringing profitable drug products to market...
Latest News
A newly proposed cost-cutting rule implemented into the US Medicaid programme could save the country up to $17.7bn over five years, say US health...
Latest Projects
The 2012 London Olympics will be the first Olympic event to have an anti-doping laboratory sponsored by a pharmaceutical...
Latest Press Releases
SCHOTT has appointed Christophe Muguet as vice president of its global syringe business. He leads this area's business activities as part of SCHOTT Pharmaceutical Packaging from the offices in...
Latest Features
Despite reductions in R&D spending, clinical trials for rare diseases are going full steam ahead. Elly Earls speaks to Alastair Kent of Genetic Alliance UK, Tim Cote of the National...
Twitter